je.st
news
Tag: gilead
Gilead Sciences Vs. Its Peers
2016-03-30 15:05:36| Biotech - Topix.net
Normally when I look at companies that have a market cap over 100 billion USD they are either growth stocks with sky-high PEs or 'boring', high dividend paying companies that have been around for decades. Gilead Sciences GILD was founded by Michael Riordan in California almost 29 years ago.
Tags: sciences
peers
gilead
gilead sciences
Gilead Verdict: Who Won, Who Lost
2016-03-28 16:58:46| Biotech - Topix.net
Gilead Sciences has been locked in litigation with Merck and Ionis Pharmaceuticals over a patent dispute regarding Gilead's drugs Harvoni and Sovaldi. I have previously written about Gilead's next steps after litigation here , and about the impact of the litigation on Ionis Pharmaceuticals, which can be found here .
Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.
2016-03-27 07:36:47| Biotech - Topix.net
's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
2016-03-25 15:53:27| Biotech - Topix.net
The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which lie at the heart of the dispute over Gilead's blockbuster drugs Sovaldi and Harvoni.
Tags: pay
million
drug
ordered
Jury finds for Merck in hepatitis drug fight with Gilead
2016-03-23 00:19:12| Biotech - Topix.net
A federal jury in California has ruled in favor of drugmaker Merck in a high-stakes lawsuit against rival Gilead Sciences concerning patents for lucrative new drugs for hepatitis C. Merck accused Gilead of infringing on patents it filed over a decade ago, claiming Gilead's sofosbuvir infringes on those patents. Sofosbuvir is the active ingredient in Gilead's Sovaldi and a component of its Harvoni, which together brought in $19.1 billion last year.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »